Anti-cancer Effects of a Novel Curcumin Derivative, 4,4-Diallyl Curcumin Bis(2,2-Hydroxymethyl)Propanoate (35e), on Radio-resistant Colorectal Cancer Cells

• Published in: Anticancer research Vol. 45; no. 7; pp. 2891 - 2904
• Main Authors: HUANG, CHING-WEN, YANG, JAI-SING, TSAI, YUH-FENG, KUO, SHENG-CHU, JUAN, YU-NING, LIN, MENG-WEI, CHIU, YU-JEN, HSU, CHUNG-HUA
• Format: Journal Article
• Language: English
• Published: Greece 01.07.2025
• Subjects: Antineoplastic Agents - pharmacology; Apoptosis - drug effects; Cell Proliferation - drug effects; Cell Survival - drug effects; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - genetics; Colorectal Neoplasms - metabolism; Colorectal Neoplasms - pathology; Colorectal Neoplasms - radiotherapy; Curcumin - analogs & derivatives; Curcumin - pharmacology; Gene Expression Regulation, Neoplastic - drug effects; HT29 Cells; Humans; Radiation Tolerance - drug effects; Signal Transduction - drug effects; Curcumin derivative; colorectal cancer; radio-resistant

Failure of radiotherapy is a major factor leading to poor prognosis in colorectal cancer. This study investigated the anticancer effects of a novel curcumin derivative, 4,4-diallyl curcumin bis(2,2-hydroxymethyl)propanoate (35e), on radio-resistant colorectal cancer cells (HT29/RR). HT29/RR cells we...